Pilot program in China to commercialize new pharmaceutical drugs

Chinese pharmaceutical companies have always found it difficult to commercialize their patents. A national pilot program will help to solve that problem. More than 300 small- and medium-sized biopharma companies have settled in the Zhangjiang Hi-tech Park located in the Pudong district of Shanghai.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Spotlight

Resources